Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2 publications
Avutometinib, Abemaciclib, and Fulvestrant in Patients with HR+/HER2- Metastatic Breast Cancer Previously Treated with CDK4/6 Inhibitor: A Single-Arm Phase I Trial.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: February 19, 2026
Showing 1-2 of 2
Last Updated: 09/26/2026